We are live on ! Find out more
NVO

Novo Nordisk
NVO

1,277 hedge funds and large institutions have $12.4B invested in Novo Nordisk in 2026 Q1 according to their latest regulatory filings, with 150 funds opening new positions, 446 increasing their positions, 474 reducing their positions, and 274 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.31% more ownership

Funds ownership: 9.3% → 9.62% (+0.31%)

6% less repeat investments, than reductions

Existing positions increased: 446 | Existing positions reduced: 474

10% less funds holding

Funds holding: 1,418 → 1,277 (-141)

23% less capital invested

Capital invested by funds: $16.1B → $12.4B (-$3.75B)

33% less call options, than puts

Call options by funds: $1.44B | Put options by funds: $2.14B

45% less funds holding in top 10

Funds holding in top 10: 20 → 11 (-9)

45% less first-time investments, than exits

New positions opened: 150 | Existing positions closed: 274

Holders
1,277
Holders Change
-141
Holders Change %
-9.94%
% of All Funds
15.63%
Holding in Top 10
11
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-45%
% of All Funds
0.13%
New
150
Increased
446
Reduced
474
Closed
274
Calls
$1.44B
Puts
$2.14B
Net Calls
-$701M
Net Calls Change
+$511M

Top Buyers

Rank Fund Capital Flow
1
Dodge & Cox
Dodge & Cox
California
+$916M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$468M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$371M
4
Two Sigma Investments
Two Sigma Investments
New York
+$282M
5
Capital World Investors
Capital World Investors
California
+$237M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$411M
2
Goldman Sachs
Goldman Sachs
New York
-$278M
3
Boston Partners
Boston Partners
Massachusetts
-$248M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
-$245M
5
Citadel Advisors
Citadel Advisors
Florida
-$221M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1226
Raleigh Capital Management
North Carolina
$2.65K +$3.41K +72 New
HCM
1227
Horrell Capital Management
Arkansas
$2.57K – – –
MA
1228
Montag & Associates
Georgia
$2.54K – – –
HI
1229
Hoey Investments
Pennsylvania
$2.5K -$2.37K -50 -42%
BDPWM
1230
Barnes Dennig Private Wealth Management
Ohio
$2.5K – – –
FDW
1231
Fourth Dimension Wealth
Ohio
$2.43K -$805 -17 -20%
DF
1232
DecisionPoint Financial
Arizona
$2.43K – – –
FG
1233
Fairman Group
Pennsylvania
$2.39K – – –
MWM
1234
Mosley Wealth Management
California
$2.39K +$2.04K +43 New
NIG
1235
NFJ Investment Group
Texas
$2.31K – – –
ECA
1236
Elevated Capital Advisors
Utah
$2.24K – – –
EWP
1237
Elevation Wealth Partners
California
$2.24K – – –
DPW
1238
DiNuzzo Private Wealth
Pennsylvania
$2.21K – – –
HWM
1239
HighMark Wealth Management
Minnesota
$2.16K – – –
BAM
1240
Bellevue Asset Management
Washington
$2.13K – – –
TBFA
1241
Three Bearings Fiduciary Advisors
New Hampshire
$2.05K – – –
ST
1242
Smithfield Trust
Pennsylvania
$2K -$95 -2 -3%
CFG
1243
CKW Financial Group
Hawaii
$2K – – –
CHC
1244
City Holding Co
West Virginia
$1.87K – – –
GA
1245
GoalVest Advisory
New York
$1.87K – – –
EP
1246
Essential Partners
California
$1.73K +$2.23K +47 New
Federated Hermes
1247
Federated Hermes
Pennsylvania
$1.69K – – –
ACA
1248
American Capital Advisory
Idaho
$1.65K +$663 +14 +45%
DWM
1249
Dogwood Wealth Management
Kansas
$1.62K +$2.08K +44 New
HFM
1250
Hartford Financial Management
Connecticut
$1.54K -$8.81K -186 -82%
48 49
50
51 52

NVO Hedge Fund Activity: Q1 2026 in Review

1,277 of the 8,172 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2026, worth a combined $12.4B — down 23% from $16.1B a quarter earlier.

Sellers outnumbered buyers: 274 funds closed out of NVO and 150 opened new positions — a net loss of 124 holders — while 474 trimmed existing stakes and 446 added.

The largest buyer was Dodge & Cox, opening a new position worth an estimated $916M. The largest seller was Fidelity Investments, cutting an estimated $411M.

  • 1,277 institutional investors held Novo Nordisk (NVO) as of Q1 2026, down from 1,418 in Q4 2025.
  • Funds reported $12.4B of Novo Nordisk stock for Q1 2026, down 23% quarter-over-quarter.
  • 150 funds opened new Novo Nordisk positions in Q1 2026 and 274 closed out, a net change of -124 holders.
  • The largest Novo Nordisk buyer in Q1 2026 was Dodge & Cox, an estimated $916M added.
  • The largest Novo Nordisk seller in Q1 2026 was Fidelity Investments, an estimated $411M sold.

Based on aggregated 13F filings for Q1 2026.